This two-phase retrospective study was designed to evaluate the impact of the clinical pharmacist on prescribing practice of physicians in an internal medicine service. Streptococcal (pneumococcal) pneumonia was chosen as the model disease state. The drug of choice was used more frequently and there was a statistically significant difference in raw cost of antibiotic, total cost for antibiotic administration, daily raw cost for antibiotics; total raw cost for antibiotic administration, and patient charges when physicians were exposed to the clinical pharmacists' influence.
DimondEG. The academic plan for the school of medicine. Kansas City: University of Missouri-Kansas City, 1977.
2.
CountsGW. Review and control of antimicrobial usage in hospitalized patients. A recommended collaborative approach. JAMA1977; 238: 2170–4.
3.
SimmonsHEStollyPD. This is medical progress? Trends and consequences of antibiotic use in the United States. JAMA1974; 227: 1023–8.
4.
SherrisJC. The epidemiology of drug resistance. In: BrachmanPSEickhoffTC, eds. Proceedings of the International Conference of Nosocomial Infections. Baltimore: Waverly Press, Inc., 1971: 50–60.
5.
The medical letter on drugs and therapeutics.Handbook on antimicrobial therapy. New Rochelle, NY: Medical Letter, Inc.Revised edition, 1976.
6.
BorrowsSN. Anuria and acute tubular necrosis associated with gentamicin and cephalothin. JAMA1972; 222: 1546–7.
7.
FillastreJPLaumonierR, Acute renal failure associated with combined gentamicin and cephalothin therapy. Br Med J1973; 2: 396.
8.
FanningWLGumpDJickH.Gentamicin and cephalothin associated rises in blood urea nitrogen. Antimicrob Agents Chemother1976; 10: 80–3.
9.
LuftFCPatelVYumMNKleitSA. Nephrotoxicity of cephalosporin-gentamicin combinations in rats. Antimicrob Agents Chemother1976; 9: 831–9.
10.
CovinskyJO. The role of the clinical pharmacist in medical education. J Clin Pharmacol1981; 21: 198–200.
